By October 2019, the treatments had been succcessful, but four years later, in March 2023, the cancer returned—this time a different, more aggressive kind of breast cancer, called Her2+.

The double mastectomy, undertaken by some breast cancer patients as a precautionary measure, provides no advantage to sufferers when it comes to survival, a new study has revealed. The findings ...

Breast Cancer Combination Therapy Continues To Be Effective. Five years later, Beatriz is still on the triplet therapy as part of the phase 1 trial. She has tolerated the drugs well, and her cancer ...

Per Susan G. Komen, people diagnosed with stage 1 breast cancer have a 98 to 100 percent five-year survival rate; stage 2 comes with a 90 to 99 percent survival rate.

In February 2023, I was diagnosed with Stage I breast cancer—and I'm ready to share my story now in a way that I hope is useful. This wasn't my first cancer scare.